CD200 and acute myeloid leukemia: To analyse the effect of TTI‐CD200 in vivo, a robust source of adoptive immune cells which could be co‐engrafted with AML blast cells into NOD‐SCID IL2Rγ(‐/‐) (NSG) mice was required.